The risks and benefits of an RX-to-OTC switch: The case of over-the-counter H2-blockers

Gerry Oster, Daniel M. Huse, Thomas E. Delea, Graham A. Colditz, James M. Richter

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'The risks and benefits of an RX-to-OTC switch: The case of over-the-counter H2-blockers'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences